In T2DM, hyperactivated MTOR inhibits normal phosphorylation of insulin substrates, affecting insulin sensitivity and thereby increasing insulin resistance, which in turn leads to apoptosis through upregulation of mitogen-activated protein kinase 8 (MAPK8) [25]. The gene discussed is MAP3K8; the disease is type 2 diabetes mellitus.